<- Go Home

Tecan Group AG

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, sequencing reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service. Tecan Group AG has a strategic collaboration with NVIDIA Corporation to develop AI-enabled platform for data-driven laboratories to help discoveries and lab productivity. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.

Market Cap

CHF 2.2B

Volume

52.9K

Cash and Equivalents

CHF 176.4M

EBITDA

CHF 80.9M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

CHF 310.8M

Profit Margin

35.22%

52 Week High

CHF 181.20

52 Week Low

CHF 110.60

Dividend

1.70%

Price / Book Value

1.93

Price / Earnings

-20.24

Price / Tangible Book Value

5.89

Enterprise Value

CHF 2.1B

Enterprise Value / EBITDA

22.82

Operating Income

CHF 45.0M

Return on Equity

8.56%

Return on Assets

1.47

Cash and Short Term Investments

CHF 311.4M

Debt

CHF 218.3M

Equity

CHF 1.2B

Revenue

CHF 882.5M

Unlevered FCF

CHF 115.3M

Sector

Life Sciences Tools and Services

Category

N/A

Company Stock Pitches